RENAL TREATMENT CENTERS-SOUTHEAST, LP.
NPI: 1104885243
· BOGALUSA, LA 70427
· End-Stage Renal Disease (ESRD) Treatment Clinic/Center
· NPI assigned 03/18/2006
Billing Flags
· Automated signals — not evidence of fraud
Entity Proliferation
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
Provider Details
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/18/2006 |
Related Entities
Other providers sharing the same authorized official: WEY, SAMUEL
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2018 |
4,262 |
$1K |
| 2019 |
4,482 |
$4K |
| 2020 |
3,393 |
$2K |
| 2023 |
115 |
$9K |
| 2024 |
409 |
$53K |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
524 |
101 |
$62K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
8,687 |
524 |
$7K |
| A4657 |
Syringe, with or without needle, each |
1,760 |
680 |
$0.00 |
| 82728 |
|
177 |
157 |
$0.00 |
| 83550 |
|
149 |
130 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
37 |
14 |
$0.00 |
| 85041 |
|
365 |
325 |
$0.00 |
| 83540 |
|
149 |
130 |
$0.00 |
| 85048 |
|
335 |
304 |
$0.00 |
| 83970 |
|
346 |
305 |
$0.00 |
| 82108 |
|
132 |
117 |
$0.00 |